Merion, Inc. entered into an agreement to acquire all of the assets associated with the manufacture of dietary supplements from Suss Technology Corporation for $1.4 million on January 1, 2018. As per the terms of agreement, Merion will issue 1 million of its common stock which will be transferred within 30 days of agreement and pay $1 million in cash which will be paid in in two distributions of $0.6 million within six months of the date of the agreement and $0.4 million within twelve months of the date of the agreement. Payment of consideration is subject to asset sale and completion of all applications for relevant business and manufacturing licenses for Merion benefit. Suss Technology cash and cash equivalents, minute books, stock ledger and other company records, as well as raw materials and customer lists shall remain with the Suss Technology and Merion will assume the Suss Technology obligations under a lease of real property used in the Suss Technology business. Acquisition is subject to regulatory approvals and other customary closing conditions. Jeffrey Li of Garvey Schubert & Barer acted as legal advisor of Merion and Phil W. Su as a legal advisor of Suss Technology Corporation.